Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

S. Bastuji-Garin, B. Rzany, R. S. Stern, N. H. Shear, L. Naldi and J. C. Roujeau
Department of Dermatology, Henri-Mondor Hospital, University of Paris XII, Creteil, France.

BACKGROUND AND DESIGN. To conduct a prospective case-control study about causative factors of severe bullous erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, we needed to define criteria for classifying the cases and standardize the collection of data so that cases could be reliably diagnosed according to this classification. Based on review of case histories and photographs of patients, a group of experts proposed a classification based on the pattern of erythema multiforme-like lesions (categorized as typical targets, raised or flat atypical targets, and purpuric macules) and on the extent of epidermal detachment. An atlas illustrating this classification that included photographs and schematic drawings was developed. We compared the evaluations of 28 cases by four nonphysicians relying on the atlas with the evaluations of the same cases by five experts not using the atlas to determine the usefulness of this atlas for classifying cases according to our nosologic schema. RESULTS. The following consensus classification in five categories was proposed: bullous erythema multiforme, detachment below 10% of the body surface area plus localized "typical targets" or "raised atypical targets"; Stevens-Johnson syndrome, detachment below 10% of the body surface area plus widespread erythematous or purpuric macules or flat atypical targets; overlap Stevens-Johnson syndrome-toxic epidermal necrolysis, detachment between 10% and 30% of the body surface area plus widespread purpuric macules or flat atypical targets; toxic epidermal necrolysis with spots, detachment above 30% of the body surface area plus widespread purpuric macules or flat atypical targets; and toxic epidermal necrolysis without spots, detachment above 10% of the body surface area with large epidermal sheets and without any purpuric macule or target. Using the atlas, the nonexperts showed excellent agreement with the experts. CONCLUSION. This study suggests that an illustrated atlas is a useful tool for standardizing the diagnosis of acute severe bullous disorders that are attributed to drugs or infectious agents. Whether the five categories proposed represent distinct etiopathologic entities will require further epidemiologic and laboratory investigations.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Management of toxic epidermal necrolysis and related syndromes
Mukasa and Craven
Postgrad. Med. J. 2008;84:60-65.
ABSTRACT | FULL TEXT  

Cutaneous Reactions to Drugs in Children
Segal et al.
Pediatrics 2007;120:e1082-e1096.
ABSTRACT | FULL TEXT  

"Atypical" Stevens-Johnson Syndrome?
Schalock and Dinulos
Pediatrics 2007;120:451-452.
FULL TEXT  

Cutaneous Adverse Reactions to Valdecoxib Distinct From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Ziemer et al.
Arch Dermatol 2007;143:711-716.
ABSTRACT | FULL TEXT  

Treatment of Severe Adverse Cutaneous Drug Reactions With Human Intravenous Immunoglobulin in Two Dogs
Trotman et al.
Journal of the American Animal Hospital Association 2006;42:312-320.
ABSTRACT | FULL TEXT  

SEVERE CUTANEOUS REACTIONS TO SULFADOXINE-PYRIMETHAMINE AND TRIMETHOPRIM-SULFAMETHOXAZOLE IN BLANTYRE DISTRICT, MALAWI.
GIMNIG et al.
Am J Trop Med Hyg 2006;74:738-743.
ABSTRACT | FULL TEXT  

Case 34-2005 -- A 10-Year-Old Girl with a Bullous Skin Eruption and Acute Respiratory Failure.
Sheridan et al.
NEJM 2005;353:2057-2066.
FULL TEXT  

Uncovering Histologic Criteria With Prognostic Significance in Toxic Epidermal Necrolysis
Quinn et al.
Arch Dermatol 2005;141:683-687.
ABSTRACT | FULL TEXT  

Cell-Mediated Immunologic Mechanism and Severity of TEN
Faye et al.
Arch Dermatol 2005;141:775-776.
FULL TEXT  

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics
Mockenhaupt et al.
Neurology 2005;64:1134-1138.
ABSTRACT | FULL TEXT  

Complications of Therapy in Cancer Patients: CASE 3. Toxic Epidermal Necrolysis Induced by Oral Phenobarbital and Whole-Brain Radiotherapy in a Breast Cancer Patient
Vincenzi et al.
JCO 2004;22:4649-4651.
FULL TEXT  

Early Diagnosis Is Key in Vancomycin-Induced Linear IgA Bullous Dermatosis and Stevens-Johnson Syndrome
Jones et al.
JAOA: Journal of the American Osteopathic Association 2004;104:157-163.
ABSTRACT | FULL TEXT  

Use of Intravenous Immunoglobulin in Children With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Seven Cases and Review of the Literature
Metry et al.
Pediatrics 2003;112:1430-1436.
ABSTRACT | FULL TEXT  

Photo-Induced Stevens-Johnson Syndrome Due to Sulfasalazine Therapy
Borras-Blasco et al.
The Annals of Pharmacotherapy 2003;37:1241-1243.
ABSTRACT | FULL TEXT  

Case 23-2003 - A 79-Year-Old Woman with Gastric Lymphoma and Erosive Mucosal and Cutaneous Lesions
Ahmed et al.
NEJM 2003;349:382-391.
FULL TEXT  

Possible Cefotaxime-Induced Stevens-Johnson Syndrome
Liberopoulos et al.
The Annals of Pharmacotherapy 2003;37:812-814.
ABSTRACT | FULL TEXT  

Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome Are Induced by Soluble Fas Ligand
Abe et al.
Am. J. Pathol. 2003;162:1515-1520.
ABSTRACT | FULL TEXT  

Outbreak of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Mebendazole and Metronidazole Use Among Filipino Laborers in Taiwan
Chen et al.
Am. J. Public Health 2003;93:489-492.
ABSTRACT | FULL TEXT  

Treatment of Toxic Epidermal Necrolysis With High-Dose Intravenous Immunoglobulins: Multicenter Retrospective Analysis of 48 Consecutive Cases
Prins et al.
Arch Dermatol 2003;139:26-32.
ABSTRACT | FULL TEXT  

Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis: Results of an International Prospective Study
Auquier-Dunant et al.
Arch Dermatol 2002;138:1019-1024.
ABSTRACT | FULL TEXT  

Outcome of Toxic Epidermal Necrolysis
Krowchuk
AAP Grand Rounds 2002;7:54-54.
FULL TEXT  

Soluble Interleukin 2 Receptor and Interleukin 1{alpha} in Toxic Epidermal Necrolysis: A Comparative Analysis of Serum and Blister Fluid Samples
Correia et al.
Arch Dermatol 2002;138:29-32.
ABSTRACT | FULL TEXT  

Parvovirus Infection of Keratinocytes as a Cause of Canine Erythema Multiforme
Favrot et al.
Vet Pathol 2000;37:647-649.
ABSTRACT | FULL TEXT  

Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome
Leaute-Labreze et al.
Arch. Dis. Child. 2000;83:347-352.
ABSTRACT | FULL TEXT  

Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome: Does Early Withdrawal of Causative Drugs Decrease the Risk of Death?
Garcia-Doval et al.
Arch Dermatol 2000;136:323-327.
ABSTRACT | FULL TEXT  

Improving the Outcome of Patients With Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome
Stern
Arch Dermatol 2000;136:410-411.
FULL TEXT  

Medication Use and the Risk of Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis
Roujeau et al.
NEJM 1995;333:1600-1608.
ABSTRACT | FULL TEXT  

Severe Adverse Cutaneous Reactions to Drugs
Roujeau and Stern
NEJM 1994;331:1272-1285.
FULL TEXT